The Woodlands and Houston, Texas, October 8, 2024/ Cision / – Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Mongoose Bio, a private clinical-stage biopharmaceutical company pioneering next generation precision T-cell based therapies targeting solid cancers, today announced the signing of an agreement for the Technology Transfer, Process Development, and
Category: Press Release
Cellipont Bioservices Announces Darren Head As Chief Executive Officer & Minority Growth Equity Investment From HealthQuest Capital
The Woodlands, TX, October 7, 2024 – Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced Darren Head as Chief Executive Officer. In addition to his role as Chairman of the Board, Mr. Head brings deep institutional knowledge and a wealth of biopharmaceutical leadership experience to the role. This strategic
Cellipont Bioservices and Adva Biotechnology Collaborate to Optimize Cell Therapy Manufacturing with the ADVA X3® Platform
Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Adva Biotechnology, an Israel-based private biotechnology company providing a decentralized, automated, and efficient
Cellipont Bioservices and Wugen Sign Agreement for the Clinical Manufacture of Wugen’s Off-the-shelf CAR-T Cellular Therapies
Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Wugen, Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell therapies to treat a broad range of hematological
Cellipont Bioservices Appoints Edwin Beale as Chief Commercial Officer
Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Edwin Beale as its new Chief Commercial Officer, effective immediately. Mr. Beale brings over 25 years
Cellipont Bioservices Announces Grand Opening of Its Purpose-built Cell Therapy Manufacturing Facility
Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), proudly announces the grand opening of its purpose-built 76,000 sq. ft. manufacturing facility in The Woodlands, TX.
Cellipont Bioservices Selects L7 Informatics For Its Flexible and Unified Platform, Enabling End-to-End Manufacturing
AUSTIN, Texas, Jan. 17, 2024 /PRNewswire/ — L7 Informatics, the industry leader providing scientific software solutions for research, development, manufacturing, and quality control operations, is excited to announce a strategic partnership with Cellipont Bioservices, a distinguished CDMO specializing in cell therapy manufacturing. This collaboration marks a pivotal moment as Cellipont embraces L7 Informatics’ L7|ESP™ unified
Cellipont Bioservices and Evia Bio Collaborate to Launch Cryo Excellence Center (CryoX) in Houston, TX
Houston, TX, October 11, 2023/ PRNewswire/— Cellipont Bioservices, a leading CDMO in cell therapy development and manufacturing and Evia Bio, a life sciences innovation company that develops non-DMSO cryopreservation solutions for the cell therapy industry, announced today a strategic partnership to launch a Cryopreservation Excellence Center (CryoX) at Cellipont Bioservices cGMP cell therapy manufacturing facilities
Cellipont Bioservices and Diakonos Oncology Corporation Collaborate to Develop Groundbreaking Therapy for Glioblastoma
Cellipont Bioservices, a leading CDMO in cell therapy development and manufacturing and Diakonos Oncology, announced today that they have entered into an agreement for the Process Development & cGMP Manufacturing of DOC1021, an
As new cell therapy facility in The Woodlands approaches readiness, Cellipont adds new Site Operations Head
Cellipont Bioservices announced today that Daniel Ramirez has joined the executive leadership team to oversee operations at the company’s new cell therapy manufacturing site in The Woodlands, Texas. The site is scheduled to come online in stages